NHC at a glance
NATIONAL HEALTHCARE CORP (NHC, SEC CIK 1047335) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on August 6, 2026, an 8-K current report on August 11, 2026 and Form 4 insider filings as recently as September 23, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), NATIONAL HEALTHCARE CORP (NHC) reported revenue of $1.5 billion (up 16.1% from FY2024) and net income of $120.0 million. Diluted EPS was $7.67.
- As of June 30, 2026, 28 institutional investment managers tracked by SignalX reported holding NATIONAL HEALTHCARE CORP (NHC) shares worth $1.3 billion in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by Dodson Vicki L on September 22, 2026 of 4,834 shares at $225.00 per share.
- In the last 90 days, NHC insiders reported 0 open-market purchases ($0) and 15 open-market sales ($5.6M) on Form 4, a net sale of $5.6M.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $1.5B
- +16.1% vs prior year
- Insiders · 90 days
- 0 buys · 15 sells
- Net −$5.6M
- 13F holders
- 28 funds
- $1.3B · −1 vs prior quarter
- Latest 8-K
- Aug 11, 2026
- Item 8.01
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Business Overview
- Core business: Operation of skilled nursing, assisted and independent living, homecare, hospice, and behavioral health facilities across 9 states, primarily Southeastern and Midwestern U.S.
- New expansion: Acquisition of White Oak Management with 15 skilled nursing facilities, 2 assisted living, 4 independent living, and a long-term care pharmacy adding 1,928 skilled beds in SC and NC (Aug 2024)
- Strategic emphasis: Growth in post-acute and senior health care operations, hospice agency launches in multiple locations during 2023-2024, plus continued focus on quality via Medicare’s Five-Star system (62.5% 4-5 star rating vs 38.6% industry)
- Quantitative metric: Skilled nursing facility occupancy up to 89.7% in 2025 from 88.6% in 2024; homecare served average census 3,834 patients with 339,344 visits in 2025
- Noteworthy fact: FY2026 Medicare Skilled Nursing Facility payments rose 3.2% vs PY; however, FY2026 home health agency payments projected to decline 1.3%
Risk Factors
- Regulatory risk: Medicare reimbursement cuts mandated by the Budget Control Act of 2011 impose up to 2% annual reductions extended through 2030
- Geopolitical/macro threat: CMS Staffing Rule implementation delayed by One Big Beautiful Bill Act until October 1, 2034, creating uncertainty in labor cost planning
- Operational/supply chain risk: Dispute with lessor National Health Investors, Inc. over Master Lease non-compliance risks losing lease on multiple facilities
- Competitive market risk: Not-for-profit and governmental competitors benefit from tax-exempt financing and donations, intensifying competition for patients and referrals
- Financial risk: Increasing self-insurance exposure to professional liability and workers’ compensation claims with potential for liabilities exceeding reserves
Management Discussion & Analysis
- Revenue $1.52B in 2025, up 16.1% YoY from $1.31B in 2024; net patient revenues $1.47B, up 17.4% ($217.9M)
- Operating margin 8.4% in 2025 vs 6.9% in 2024; net income margin 8.0% in 2025 vs 7.8% in 2024
- Best performing: Inpatient Services with $1.32B revenue, $127.8M operating income in 2025; Worst: "All Other" category operating loss of $(29.5)M
- Cash flow from operations $185.1M in 2025 vs $107.3M in 2024; capital expenditures $33.9M; financing cash used $136.0M (likely for debt repayment/buybacks)
- Management highlights skilled nursing census growth, White Oak acquisition accretive, labor cost management; risks include ongoing healthcare labor shortages and inflationary pressures
AI summary of the NHC 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Management Discussion & Analysis
- No profitability, margin, cash-flow, or capital-deployment figures provided
- Headwinds: labor costs, regulation, Medicare and Medicaid payment changes, litigation, staffing, competition
- Outlook risks: capital availability, cybersecurity investment, census levels, demographic changes
Risk Factors
- No risk-factors section provided in the submitted text
- Purchase and sale agreements dated April 21 and May 14, 2026 indicate transaction-related execution exposure
- No regulatory, legal, operational, competitive, market, liquidity, debt, currency, or concentration risks disclosed in the provided text
AI summary of the NHC 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 8.01: Other Events
- Quarterly common dividend announced August 6, 2026
- Dividend details and payment terms available in Exhibit 99.1
Item 2.02: Results of Operations and Financial Condition
- NHC announced earnings for the quarter ended June 30, 2026
- Exhibit 99.1 contains the complete earnings release and financial results
Item 7.01: Regulation FD Disclosure
- NHC disclosed closing of the Transaction on July 1, 2026
- Press release furnished as Exhibit 99.1 contains transaction details
Item 1.01: Entry into a Material Definitive Agreement
- $475 million senior unsecured term loan drawn at closing
- $55 million revolving credit facility draw for transaction funding
AI summaries of NHC 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for NHC
Don't miss the next NHC filing
- Alerts as it files. A push when NHC files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut NHC, by share count.
- Ask anything. An AI agent that reads every NHC filing and answers with sources.
NHC alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Dodson Vicki L | Sell | Sep 22, 2026 | 4,834.001 | $225.00 |
| KIDD BRIAN F | Sell | Sep 11, 2026 | 6,813 | $225.70 |
| McCreary Josh A | Sell | Sep 10, 2026 | 789 | $223.78 |
| McCreary Josh A | Sell | Sep 10, 2026 | 68 | $225.59 |
| McCreary Josh A | Sell | Sep 10, 2026 | 1,291 | $225.09 |
| McCreary Josh A | Sell | Sep 10, 2026 | 571 | $222.73 |
| FLATT BEN ANDERSON SR | Sell | Aug 28, 2026 | 1,000 | $222.50 |
| Gifford David R. | Sell | Aug 25, 2026 | 1,779 | $225.42 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $1.3B | $1.5B |
| Operating Income | - | $85.8M | $128.4M |
| Net Income | $66.8M | $101.9M | $120.0M |
| Op. Margin | - | 6.6% | 8.5% |
| Net Margin | - | 7.8% | 7.9% |
| Balance Sheet | |||
| Total Assets | $1.3B | $1.5B | $1.5B |
| Equity | - | $980.2M | $1.1B |
| ROE | - | 10.4% | 11.2% |
| Per Share | |||
| EPS | $4.34 | $6.53 | $7.67 |
| Cash Flow | |||
| Operating CF | - | $107.3M | $185.1M |
| CapEx | $27.9M | $27.6M | $36.4M |
Source: XBRL data in NATIONAL HEALTHCARE CORP (NHC)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate NHC share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 28 | $1.26B |
| Q1 2026 | 29 | $957.8M |
| Q4 2025 | 27 | $806.0M |
| Q3 2025 | 27 | $727.0M |
| Q2 2025 | 28 | $644.1M |
| Q1 2025 | 24 | $387.3M |
| Q4 2024 | 18 | $438.0M |
| Q3 2024 | 18 | $320.8M |
- BlackRock+80.5K (+4%)
- State Street Corp+35.2K (+7%)
- Invesco Ltd+25.1K (+17%)
- Prudential Financial+21.3K (+75%)
- Vanguard Portfolio Management LLC+19.8K (+3%)
- Two Sigma Investments−76.2K (-92%)
- Goldman Sachs Group−46.9K (-48%)
- Renaissance Technologies LLC−35.8K (-11%)
- JPMorgan Chase & Co−34.2K (-48%)
- Dimensional Fund Advisors−17.3K (-2%)
- Citadel Advisors LLC−7.9K
Source: 13F-HR filings on SEC EDGAR (aggregated from 199 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
NHC filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Sep 23, 2026 | - | - | - |
| 4 | Sep 14, 2026 | - | - | - |
| 4 | Sep 14, 2026 | - | - | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Aug 28, 2026 | - | - | - |
| 4 | Aug 21, 2026 | - | - | - |
| 4 | Aug 20, 2026 | - | - | - |
| 4 | Aug 17, 2026 | - | - | - |
| 8-K | Aug 11, 2026 | - | Analysis | - |
| 8-K | Aug 11, 2026 | - | Analysis | - |
| 10-Q | Aug 6, 2026 | Jun 30, 2026 | Analysis | |
| SC 13G | Jul 27, 2026 | - | - | |
| 8-K | Jul 1, 2026 | - | Analysis | - |
| 4 | Jun 23, 2026 | - | - | - |
| 4 | Jun 18, 2026 | - | - | - |
| 4 | Jun 18, 2026 | - | - | - |
| 4 | Jun 10, 2026 | - | - | |
| 4 | Jun 2, 2026 | - | - | |
| 8-K | May 27, 2026 | - | Analysis | |
| 4 | May 27, 2026 | - | - | |
| 4 | May 22, 2026 | - | - | |
| 4 | May 22, 2026 | - | - | |
| 4 | May 20, 2026 | - | - | |
| 4 | May 18, 2026 | - | - | |
| 4 | May 18, 2026 | - | - |
Related Health Care companies
- ENSG · ENSIGN GROUP, INCServices-Skilled Nursing Care Facilities
- PACS · PACS Group, Inc.Services-Skilled Nursing Care Facilities
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
- AARD · Aardvark Therapeutics, Inc.Pharmaceutical Preparations
- ABT · Abbott LaboratoriesPharmaceutical Preparations
- ABBV · AbbVie IncPharmaceutical Preparations
- ABEO · ABEONA THERAPEUTICS INC.Pharmaceutical Preparations
NHC SEC filings: frequently asked questions
Are NHC insiders buying or selling?
In the last 90 days, NATIONAL HEALTHCARE CORP (NHC) officers, directors and 10% owners reported no open-market purchases and 15 open-market sales worth $5.6 million by 6 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold NHC stock?
As of June 30, 2026, the largest NATIONAL HEALTHCARE CORP (NHC) holders among the 13F filers tracked by SignalX were BlackRock ($417.6 million), Dimensional Fund Advisors ($196.5 million), Vanguard Portfolio Management LLC ($171.0 million), Vanguard Capital Management LLC ($116.7 million), State Street Corp ($111.7 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was NHC's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), NATIONAL HEALTHCARE CORP (NHC) reported revenue of $1.5 billion (up 16.1% from FY2024) and net income of $120.0 million. Diluted EPS was $7.67. The figures come from the XBRL data in the 10-K.
What are the main risks in NHC's latest 10-K?
In the 10-K filed February 26, 2026, NATIONAL HEALTHCARE CORP (NHC) flagged: Regulatory risk: Medicare reimbursement cuts mandated by the Budget Control Act of 2011 impose up to 2% annual reductions extended through 2030. Geopolitical/macro threat: CMS Staffing Rule implementation delayed by One Big Beautiful Bill Act until October 1, 2034, creating uncertainty in labor cost planning. (AI summary of the Risk Factors section.)
What did NHC report in its latest 8-K?
NATIONAL HEALTHCARE CORP (NHC) filed an 8-K on August 11, 2026 reporting Item 8.01 (Other Events). Quarterly common dividend announced August 6, 2026.
What are the latest NHC SEC filings?
NATIONAL HEALTHCARE CORP (NHC) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on August 6, 2026, an 8-K current report on August 11, 2026 and a Form 4 insider filing on September 23, 2026.
What is NHC's SEC CIK number?
NATIONAL HEALTHCARE CORP (NHC)'s SEC Central Index Key (CIK) is 1047335. EDGAR lists every NHC filing under that number.
Ask anything about NHC
The research agent reads NHC's filings, financials, insider trades and 13F holders, then answers with sources.